Sign in
4

Changes in Ownership

Grace Therapeutics, Inc. Filed Acc 0000950170-24-056082

Options or other derivatives

  • Principal Financial Officer acquired 4,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
DelAversano Robert J Principal Financial Officer 2024-05-06 Grant or award · Stock Options (Right to Buy) +4,500 4,500 D: show line 1 in the form
Loading xslF345X05/ownership.xml…